ID   UACC-1308
AC   CVCL_DG39
SY   UACC 1308; UACC1308; University of Arizona Cell Culture-1308
DR   BTO; BTO_0005895
DR   Wikidata; Q54973804
RX   PubMed=23039341;
RX   PubMed=24879157;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 6
//
RX   PubMed=23039341; DOI=10.1186/1476-4598-11-75; PMCID=PMC3554420;
RA   Byron, Sara A.
RA   Loch, David C.
RA   Wellens, Candice L.
RA   Wortmann, Andreas
RA   Wu, Jia-Yi
RA   Wang, John
RA   Nomoto, Kenichi
RA   Pollock, Pamela M.
RT   "Sensitivity to the MEK inhibitor E6201 in melanoma cells is
RT   associated with mutant BRAF and wildtype PTEN status.";
RL   Mol. Cancer 11:75.1-75.15(2012).
//
RX   PubMed=24879157; DOI=10.4161/auto.28594; PMCID=PMC4091172;
RA   Goodall, Megan L.
RA   Wang, Tong
RA   Martin, Katie R.
RA   Kortus, Matthew G.
RA   Kauffman, Audra L.
RA   Trent, Jeffrey M.
RA   Gately, Stephen
RA   MacKeigan, Jeffrey P.
RT   "Development of potent autophagy inhibitors that sensitize oncogenic
RT   BRAF V600E mutant melanoma tumor cells to vemurafenib.";
RL   Autophagy 10:1120-1136(2014).
//